Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Comparison of Betaferon, Avonex, and Rebif in treatment of relapsing-remitting multiple sclerosis.
Episode 21 with Dr. Paul Matthews discussing imaging in MS
ForuMS: A Virtual Journal Club for MS Clinicians
FOCIS: Advanced Course in Basic & Clinical Immunology
The use of cytokine signature patterns: separating drug naïve, interferon and natalizumab-treated multiple sclerosis patients.
Glatiramer acetate increases phagocytic activity of human monocytes in vitro and in multiple sclerosis patients.
Plasma ubiquitin?proteasome system profile in patients with multiple sclerosis: correlation with clinical features, neuroimaging, and treatment with interferon-beta-1b.
Alpha/beta interferon is a neuronal growth factor.
Autoantibodies and pain.
A dual concurrent mechanism explains trigeminal neuralgia in patients with multiple sclerosis.
Differing trends in the incidence of vascular comorbidity in MS and the general population.
Child Neurology Society 41st Annual Meeting
A Combination Trial of Copaxone plus Estriol in Relapsing Remitting Multiple Sclerosis
Characterization and quantitation of aggregates and particles in interferon-β products: Potential links between product quality attributes and immunogenicity.
Keystone Symposium on the Gut Microbiome: The Effector/Regulatory Immune Network
Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial.
Effect of vitamin D on MS activity by disease-modifying therapy class.
Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine.
[The overall assessment of the quality of the physical health of patients with multiple sclerosis after the application of physical therapy. Part 1].
Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.
Alemtuzumab vs. interferon beta-1a in early multiple sclerosis.
Episode 28 with Dr. Brenda Banwell on pediatric MS
EMD Serono and Pfizer announce FDA approval of Rebif® Rebidose® (interferon beta-1a)
Tumefactive multiple sclerosis presenting with tonic-clonic seizure.
Urinary incontinence in multiple sclerosis: prevalence, severity and impact on patients' quality of life.

Pages